Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Droia Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Droia Ventures

Droia Ventures

Operating

Droia Ventures: Specialist investor in drug development firms, accelerating novel science for patient impact.

Location
Luxembourg, Luxembourg Canton, LU
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Droia Ventures is a specialist investor focused on drug development companies, particularly those advancing novel science and innovative approaches to bring promising drug candidates to patients. They typically invest in early to mid-stage rounds, including Seed, Series A, Series B, and Series C, with a strong emphasis on accelerating the clinical progress of young drug development firms.

Notable portfolio companies include Accent Therapeutics, Actio Biosciences, and Arcus Biosciences. Droia Ventures is led by key partners who bring extensive experience in the biotech sector. The firm offers unique value-add services such as strategic guidance and operational support to help portfolio companies navigate the complexities of drug development and achieve clinical milestones efficiently.

Droia Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments17
Current Portfolio Count10
Total Portfolio Exits1

Top Investment Stages

Series A6 (35.3%)
Series B4 (23.5%)
Seed3 (17.6%)
Series C3 (17.6%)
Series Unknown1 (5.9%)

Stage Mix

Series A 35%Series B 24%Seed 18%Series C 18%Series Unknown 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Accent Therapeutics logo

Accent Therapeutics

Hyku logo

Hyku

Actio Biosciences logo

Actio Biosciences

QurAlis logo

QurAlis

Volastra Therapeutics logo

Volastra Therapeutics

Vicinitas Therapeutics logo

Vicinitas Therapeutics

Ambagon Therapeutics logo

Ambagon Therapeutics

Frontier Medicines logo

Frontier Medicines

Pact Pharma logo

Pact Pharma

Arcus Biosciences logo

Arcus Biosciences

Normoxys logo

Normoxys

Droia Ventures - Similar Investment Firms

Inbio Ventures logo

Inbio Ventures

Dreavent Capital logo

Dreavent Capital

Delphi Ventures logo

Delphi Ventures

delphiventures.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Dria Ventures logo

Dria Ventures

dria.com

Dream Ventures logo

Dream Ventures

dreamventures.com

Dreampact logo

Dreampact

dreampact.com

DSM Venturing logo

DSM Venturing

venturing.dsm.com

dRx Capital logo

dRx Capital

drxcapital.com

Distributed Ventures logo

Distributed Ventures

distributedvc.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Viralety Ventures logo

Viralety Ventures

viralety.com

Pitchdrive logo

Pitchdrive

pitchdrive.com

Seek Ventures logo

Seek Ventures

seekventures.com

Valia Ventures logo

Valia Ventures

valia.vc

Droia Ventures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end